HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 102 | 107 | 95.3% | |
| HF004 | 2020 | 108 | 113 | 95.6% | |
| HF006 | 2021 | 136 | 148 | 91.9% | |
| HF006 | 2022 | 147 | 154 | 95.5% | |
| HF006 | 2023 | 186 | 192 | 96.9% |
